TY  - JOUR
AU  - González Vera, Juan Antonio
AU  - Medina Muñoz, Rocío Almudena
AU  - Martín-Fontecha Corrales, María Del Mar
AU  - Gonzalez Wong, Ángel
AU  - Fuente Mendizábal, Tania de la
AU  - Vázquez Villa, María Del Henar
AU  - García Cárceles, Javier
AU  - Botta, Joaquín
AU  - McCormick, Peter J.
AU  - Benhamú Salama, Bellinda
AU  - Pardo Carrasco, Leonardo
AU  - López Rodríguez, María Luz
PY  - 2017
DO  - 10.1038/srep41293
SN  - 2045-2322
UR  - https://hdl.handle.net/20.500.14352/18265
T2  - Scientific Reports
AB  - Serotonin 5-HT 6 receptor has been proposed as a promising therapeutic target for cognition enhancement though the development of new antagonists is still needed to validate these molecules as a drug class for the treatment of Alzheimer's disease and...
LA  - eng
PB  - Nature Publishing Group
KW  - Serotonin
KW  - 5-HT6 receptor antagonist
KW  - Drug development
KW  - Structure-based drug design
KW  - Cognition enhancement
KW  - Alzheimer's disease
KW  - MEmory deficiency
TI  - A new serotonin 5-HT 6 receptor antagonist with procognitive activity - Importance of a halogen bond interaction to stabilize the binding
TY  - journal article
VL  - 7
ER  -